Chairperson, Danny Katz, General Manager, Bristol-Myers Squibb
Committee Members:
-
Mati Gil, CEO, Aion Labs
-
Dror Harats, CEO, Vascular Biogenics Ltd.
-
Metin Hullu, Country Manager, Pfizer Pharmaceuticals Israel
-
Yoel Lipschitz, VP Regulatory Affairs & Market Access, Medison Pharma
-
Avi Buskila, CEO, SAREL Logistics Solutions & Producrs for Advanced Medicin Ltd.
-
Tina Meerry Melusyan, Country Lead, Sanofi Ltd.
-
Tammy Altarac, Managing Director, MSD Israel
-
Dalit Hazan, VP Regulatory Affair, PolyPid Ltd.
-
Avraham Raz, CEO, Eli Lilly Israel Ltd.
-
Shira Oberlande, Head of Commercial and Strategic Partnerships, Medronic Trading
-
Avi Danziger, General Manager, Roche Pharmaceuticals (Israel) Ltd
-
Chaim Martin, VP Market Access & External Affairs, Pharma Israel
- Michal Chomski Haselman, Dir Government Affairs, Teva Pharmaceutical Industries Ltd.
-
Avi Wener, Israel County Director, Thermo Fisher Scientific
-
Avi Matan, General Manager Israel, Abbvie Biopharmaceuticals Ltd.
- Gad Reshef, CEO, Indolex Pharmatech
-
Anat Haas Mizrahi, Senior Vice President, Legal Affairs and General Manager, Karyopharm Israel Ltd.
- Amir Levin CEO, Rafa Labs
Zohar Yahalom, HFN, Legal Advisor
Idit Chernovitz, Committee Consultant